🔎 Trials Near Me

Dachaigh › Galar Alzheimer › Michigan

Sgrùdaidhean clionaigeach Galar Alzheimer ann an Michigan

Tha 15 sgrùdaidhean airson Galar Alzheimer a’ lorg phàirtichean aig làraichean ann an Michigan.

Bailtean ann an Michigan

Teacsa sgrùdaidh oifigeil (Beurla)

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  • Local Institution - 1620, Troy
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06937229

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

  • Quest Research Institute, Farmington Hills
A’ fastadhÌre 4
Aoisean 50 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07633470

A Study of LY3439539 in Participants With Alzheimer's Disease

  • QUEST Research Institute, Farmington Hills
A’ fastadhÌre 1
Aoisean 50 gu 85 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07598370

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  • Neurobehavioral Medicine Group (NBMG), Bloomfield Township
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06585787

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • QUEST Research Institute, Farmington Hills
A’ fastadhÌre 2
Aoisean 55 gu 85 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07589595

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

  • Quest Research Institute, Farmington Hills
A’ fastadhÌre 3
Aoisean 50 gu 90 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT07177352

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • QUEST Research Institute, Farmington Hills
A’ fastadhÌre 3
Aoisean 60 gu 85 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06976203

A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  • NeuroBehavioral Medicine Group, Bloomfield Hills
  • Oakland Medical Research, Troy
A’ fastadhÌre 3
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07011732

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

  • Michigan Medicine, Ann Arbor
A’ fastadh
Aoisean 70 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT05929703

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

  • Local Institution - 0088, Sterling Heights
A’ fastadhÌre 2
Aoisean 55 gu 90 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT06808984

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  • Henry Ford Health System, Detroit
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT06563895

Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application Trial

  • Shiawasee Health Department, Corunna
  • McLaren Flint OB-GYN, Flint
  • Munson Gaylord OB-GYN, Gaylord
  • agus 5 a bharrachd
A’ fastadh
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 24 Iuch 2026 · NCT07213284

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Revival Research Institute, LLC, Southfield
A’ fastadhÌre 3
Aoisean 55 agus nas sine · Gach gnè · Air ùrachadh 7 Iuch 2026 · NCT07602582

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

  • QUEST Research Institute, Farmington Hills
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 45 gu 85 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06657768

Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

  • Quest Research Institute, Farmington Hills
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Aoisean 60 gu 90 · Gach gnè · Air ùrachadh 15 Gibl 2026 · NCT06584357

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.